---
title: Lonza Cell & Gene Technologies vs Rezon Bio
slug_a: lonza
slug_b: rezonbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/lonza/rezonbio
---

# Lonza Cell & Gene Technologies vs Rezon Bio

Side-by-side profile data from each company listing on this directory.

## Lonza Cell & Gene Technologies

- Profile: [/companies/lonza](/companies/lonza)

Lonza Cell & Gene Technologies — Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.

Services: 20. Modalities: 4. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (20).

### Services

- Protein Engineering
- Regulatory Affairs
- Analytical Method Development & Validation
- Translational Research
- Microbiology Services
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Cell Therapy Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Cell-Free

## Rezon Bio

- Profile: [/companies/rezonbio](/companies/rezonbio)

Rezon Bio — European biologics CDMO offering end-to-end development and manufacturing across two GMP-certified sites in Poland, with capabilities from cell line development to commercial-scale production.

Services: 9. Modalities: 2. Indications: 0. Locations: 4. Certifications: 2. The strongest documented coverage currently appears in services (9).

### Services

- Regulatory Affairs
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Stainless Steel